Aurora Cannabis Inc. (TSE:ACB - Free Report) - Roth Capital issued their Q3 2025 earnings per share estimates for Aurora Cannabis in a research note issued on Wednesday, November 6th. Roth Capital analyst W. Kirk expects that the company will post earnings of $0.29 per share for the quarter. The consensus estimate for Aurora Cannabis' current full-year earnings is ($0.22) per share. Roth Capital also issued estimates for Aurora Cannabis' Q4 2025 earnings at $0.56 EPS.
Aurora Cannabis Stock Performance
Shares of ACB traded down C$0.11 during trading hours on Monday, hitting C$6.57. The stock had a trading volume of 358,798 shares, compared to its average volume of 1,068,843. Aurora Cannabis has a fifty-two week low of C$3.84 and a fifty-two week high of C$12.85. The company has a debt-to-equity ratio of 16.95, a quick ratio of 2.48 and a current ratio of 3.76. The firm has a 50-day moving average price of C$7.71 and a 200 day moving average price of C$8.16. The firm has a market capitalization of C$359.12 million, a price-to-earnings ratio of -10.60 and a beta of 2.71.
Insider Activity at Aurora Cannabis
In other Aurora Cannabis news, Senior Officer Andre Jerome sold 7,712 shares of the firm's stock in a transaction on Monday, September 23rd. The stock was sold at an average price of C$7.70, for a total value of C$59,382.40.
Aurora Cannabis Company Profile
(
Get Free Report)
Aurora Cannabis Inc, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products.
Recommended Stories
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
